发明名称 Composition useful in the treatment of pathologies associated with e.g. hyperglycemia, diabetes, dyslipidemia, obesity, arterial hypertension, neuropathies, and nephropathies, comprises oxamate derivatives
摘要 Composition comprises oxamate derivatives containing substituted nitrogen heterocycle, their tautomeric forms, enantiomers, diastereoisomers, epimers or salts. Composition comprises oxamate derivatives containing substituted nitrogen heterocycle of formula (I), their tautomeric forms, enantiomers, diastereoisomers, epimers or salts. R, R<1>-R<4> = H or 1-3C alkyl; X = O, S, CR<5>R<5>' or NR<6>; R<5>, R<5>' = H, OH, 1-5C alkyl, CO-R<7> or 6-14C aryl (optionally substituted); R<6> = 1-10C alkyl, 2-10C alkene, 6-14C aryl, 5-8 membered heterocyclic radical (comprising at least one of O, N or S) (all optionally substituted), H, R<8>-(CH2)m-C(=O)-(CH2)n or sulfonyl (optionally substituted by at least one T); T = 1-20C alkyl, perfluoroalkyl, 6-14C aryl, 5-8 membered cycloalkyl or 5-8 membered heterocyclic (comprising at least one O, N or S) or styryl (all optionally substituted); m, n = 0 or 1; R<7> = OH, 1-5C alkyl, 1-5C alkoxy, 6-14C aryl or 6-14C aryloxy; R<8> = 2-5C alkene, 5-8 membered cycloalkyl or cycloalkoxy, 6-14C aryl, 6-14C aryloxy, 5-8 membered heterocyclic or heteroaryloxy (containing at least one O, N or S) (all optionally substituted), H, OH, 1-5C alkoxy, 1-5C alkyl or NR<9>R'<9>; R<9>, R'<9> = 1-5C alkyl, 6-14C aryl (both optionally substituted), H or COR<7>; R<9>+R'<9> = 3-10 membered ring optionally containing at least one O, N or S. Provided that when X represents NR<6> then R<1> and R<6> can together form a 3-10 membered ring optionally containing at least one O, N or S. Independent claims are also included for: (1) new oxamate derivatives of formula (I) (provided that when X is NR<6>, then R<6> is other than phenyl (substituted in the para position by a methyl and in the meta position by a halogen), benzyl or beta -phenethyl radical; when X is O then R<1>-R<4> other than H; and when X is CR<5>R'<5> then R<1>-R<5> and R'<5> are other than H); and (2) preparation of (I).
申请公布号 FR2829766(A1) 申请公布日期 2003.03.21
申请号 FR20010011950 申请日期 2001.09.14
申请人 LIPHA 发明人 MOINET GERARD;LERICHE GERARD
分类号 A61P3/00;A61P5/00;A61P9/00;C07D211/32;C07D211/34;C07D213/61;C07D213/74;C07D215/36;C07D239/42;C07D295/185;C07D295/205;C07D295/26;C07D307/24;C07D307/68;C07D317/58;C07D333/34;C07D333/38;C07D333/62;C07D487/04 主分类号 A61P3/00
代理机构 代理人
主权项
地址